Skip to search formSkip to main contentSkip to account menu

anti-C100-3

Known as: anti C100-3 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Hepatitis C Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
EFFECT OF HOSTAZYM C 100 ON GROWTH PERFORMANCE AND SOME HEMATOLOGICAL AND ETHOLOGICAL INDEXES OF YEARLING RAMS
VARLYAKOV, I., N. GRIGOROVA and T. SLAVOV, 2010. Effect of Hostazym C 100 on growth performance and some hematological and… 
1999
1999
C100 先天性胆道拡張症術後における血清胆汁酸値の検討(胆道拡張症・合流異常)
1994
1994
Study of HCV RNA and several HCV antibodies in chronically hemodialized patients
当院における維持血液透析患者59名 (男性32名, 女性27名, 平均年齢60.7歳, 平均透析期間4.9年) のHCV-RNAおよびそのgenotype, HCV抗体 (第二世代抗体, C100-3抗体, N14抗体, GOR… 
1993
1993
[Clinical investigation of HCV antibodies positive cases in the district with high mortality rate of liver diseases in Saga Prefecture].
The mortality and morbidity rates of chronic liver disease (CLD) have been extremely high for several years at Saga prefecture in… 
1993
1993
透析医療におけるC型肝炎ウイルス (HCV) 感染症の疫学
C100-3抗体を用いた血清疫学的検討から, 透析患者でHCV感染率の高いことが指摘された. 輸血の関与が主因といわれるが, 陽性率は輸血の有無で差がないとの報告もある.感染経路を明らかにし, 予防法を確立する目的で, 維持透析患者1,080名, CAPD… 
1993
1993
HCV (C100-3)抗体スクリーニング後の輸血例におけるHCV感染状況と病態に関する研究
輸血血のC100-3抗体スクリーニング後の輸血血におけるHCV感染状況と病態について検討するため,経時的に観察し得た輸血例209例につき各種HCV抗体(C100-3抗体,GOR抗体,第二世代抗体)を測定した.209例のうち,確診例は7例(3.3… 
1993
1993
CLINICAL SIGNIFICANCE OF ANTI-GOR TESTING OF SERA FROM PATIENTS WITH ABNORMAL LIVER FUNCTION DETECTED BY A REGULAR CHECK-UP
To evaluate the clinical significance of anti-GOR testing at a regular check-up, we examined 188 serial stored sera from 55… 
1992
1992
Preliminary report on seroepidemiology of HCV and HBV infection in northern China.
1 141 serum samples from various population groups in north China were examined for C100-3Ab by ELISA. Antibody to C100-3 antigen… 
1992
1992
Follow-up and clinicopathological studies of anti-C100-3 positive blood donors.
C100-3抗体陽性献血者178例の追跡調査ならびに臨床病理学的検討により,約50%が6ヵ月以上ALTが持続正常で,これらのうち約1/3はHCV-RNA陽性で,臨床的に無症候性HCVキャリアーと考えられた.一方,ALT異常を呈する例は,HCV-RNA… 
1992
1992
Successful treatment of chronic hepatitis C with interferon .ALPHA. in a hemodialysis patient.
我々は輸血後C型ウイルス肝炎を合併した透析患者にインターフェロン (IF) αを投与し著効を得たので報告する. 症例は血液透析歴6年の38歳男性で, この間計50単位の輸血を受けており, C100-3抗原 (Chiron社) を用いたHepatitis C… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)